The IKBKB Gene Immunodeficiency Type 15 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the IKBKB gene, which can lead to Immunodeficiency Type 15. This condition is part of a group of disorders that impair the immune system, making individuals more susceptible to infections and potentially leading to severe health complications. The test is crucial for early detection, allowing for timely intervention and management of the condition. Performed using advanced genetic sequencing technologies, this test offers a comprehensive analysis of the IKBKB gene to pinpoint specific mutations. The cost of the test is set at 4400 AED, reflecting the intricate processes and expertise required to accurately diagnose this immunodeficiency. By opting for this test at DNA Labs UAE, patients gain access to precise genetic insights, enabling healthcare providers to devise personalized treatment plans to manage and mitigate the impacts of Immunodeficiency Type 15.
The CD3E Gene Immunodeficiency Type 18 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CD3E gene, which are associated with a rare form of primary immunodeficiency known as Type 18. This condition is characterized by a severe impairment of the immune system, leading to increased vulnerability to infections and potentially severe immune system reactions. The test is crucial for early diagnosis and management of the condition, providing essential information for personalized treatment plans. Conducted in the advanced facilities of DNA Labs UAE, the test costs 4400 AED, reflecting the comprehensive analysis and detailed report it delivers to patients and healthcare providers.
The CD3D Gene Immunodeficiency Type 19 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the CD3D gene, which are associated with a rare form of primary immunodeficiency known as Type 19. This condition is characterized by a spectrum of immune system malfunctions, leading to an increased susceptibility to infections, autoimmune disorders, and potentially severe complications from common illnesses.
This genetic test involves analyzing the patient's DNA to detect any abnormalities or mutations in the CD3D gene that could impair the immune system's functionality. Early detection through this test can be crucial for the management and treatment of the condition, allowing healthcare providers to tailor a specific and effective treatment plan for the affected individual.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and diagnostics, known for its advanced technology and expert team of geneticists and laboratory technicians. The cost of the CD3D Gene Immunodeficiency Type 19 Genetic Test is 4400 AED. Given the complexity of the test and the specialized equipment required, this price reflects the comprehensive analysis and detailed report provided by DNA Labs UAE to help in the accurate diagnosis and management of this immunodeficiency.
The AICDA Gene Immunodeficiency Type 2 with Hyper-IgM Genetic Test is a specialized diagnostic procedure designed to identify mutations in the AICDA gene, which are responsible for a rare form of primary immunodeficiency known as Hyper-IgM Syndrome Type 2. This condition is characterized by a failure in the immune system's ability to produce adequate levels of antibodies, except for IgM, leading to increased susceptibility to infections and other immune-related issues. The test involves analyzing the patient's DNA to detect any genetic anomalies in the AICDA gene that may contribute to the disease.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability in results. With a cost of 4400 AED, it provides crucial information for the appropriate management and treatment of individuals affected by this condition. Early detection through this genetic test can significantly improve the quality of life for patients by facilitating targeted therapeutic interventions and monitoring strategies to prevent complications associated with Hyper-IgM Syndrome Type 2.
The "GATA2 Gene Immunodeficiency Type 21 Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the GATA2 gene, which are linked to a rare immunodeficiency condition known as GATA2 deficiency. This condition can lead to a variety of health issues, including increased susceptibility to infections, lymphedema, and a predisposition to certain types of leukemia and other cancers. The test is crucial for individuals who exhibit symptoms or have a family history of GATA2-related disorders, as early detection can significantly impact management and treatment strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test provides a comprehensive analysis of the GATA2 gene to detect any genetic anomalies that may contribute to the immunodeficiency. The cost of the test is set at 4400 AED, reflecting the intricate processes and advanced technology employed to ensure accurate and reliable results. By opting for this test at DNA Labs UAE, patients and healthcare providers can expect a high level of expertise and support throughout the diagnostic process, paving the way for informed decisions about treatment and care for those affected by GATA2 gene immunodeficiency.
The LCK Gene Immunodeficiency Type 22 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the LCK gene, which are associated with a rare form of immunodeficiency. This condition, known as Immunodeficiency Type 22, impacts the body's ability to fight infections due to a malfunction in the immune system. The test is crucial for early detection and management of the condition, enabling healthcare providers to devise appropriate treatment plans and interventions to improve the patient's quality of life.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any genetic abnormalities in the LCK gene. The comprehensive analysis helps in confirming the diagnosis of Immunodeficiency Type 22, providing essential information for genetic counseling and guiding decisions regarding the patient's care.
DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced geneticists and laboratory technicians, ensuring high accuracy and reliability of the test results. The lab prioritizes confidentiality and ethical standards, ensuring that patients' genetic information is handled with the utmost care and respect. This genetic test represents a critical step in managing immunodeficiency disorders, offering hope and improved outcomes for affected individuals and their families.
The "CTPS1 Gene Immunodeficiency Type 24 Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the CTPS1 gene, which are linked to a rare immunodeficiency disorder known as Type 24. This condition is characterized by the body's inability to produce sufficient amounts of certain immune cells, leading to an increased vulnerability to infections and other immune-related problems. The test is crucial for individuals who exhibit symptoms of immune deficiency or have a family history of the condition, as early detection can significantly improve management and treatment outcomes.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to look for specific alterations in the CTPS1 gene that are associated with the disease. The process is meticulous and requires a sample of the patient's blood or saliva.
The cost of the "CTPS1 Gene Immunodeficiency Type 24 Genetic Test" at DNA Labs UAE is 4400 AED. This price reflects the advanced technology and expertise required to accurately identify mutations in the CTPS1 gene. While the cost may seem high, the value of the information it provides for affected individuals and their families is immeasurable, offering insights into treatment options and helping to guide healthcare decisions.
Patients interested in undergoing this test are advised to consult with their healthcare provider to understand its benefits and implications fully.
The CD247 Gene Immunodeficiency Type 25 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the CD247 gene, which are associated with a rare form of primary immunodeficiency. This condition, known as Immunodeficiency Type 25, affects the immune system, leading to an increased susceptibility to infections and potentially other immune-related issues. The CD247 gene plays a critical role in the development and function of T cells, which are essential for the immune response.
Conducted at DNA Labs UAE, this genetic test involves analyzing the patient's DNA to detect any abnormalities in the CD247 gene that could lead to the condition. By identifying these genetic mutations, healthcare providers can better understand the nature of the immunodeficiency, leading to more personalized and effective treatment strategies for affected individuals.
The cost of the CD247 Gene Immunodeficiency Type 25 Genetic Test is 4400 AED. Given the complexity and the specialized nature of this test, it represents a crucial investment in the accurate diagnosis and management of patients with this rare immunodeficiency, ultimately contributing to improved health outcomes and quality of life for those affected.
The "CD40 Gene Immunodeficiency Type 3 with Hyper-IgM Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the CD40 gene, which are implicated in a rare form of immunodeficiency known as Hyper-IgM Syndrome Type 3. This condition is characterized by a defective immune response, primarily affecting the body's ability to produce antibodies against pathogens. Patients typically present with recurrent infections, due to their inability to switch from the production of immunoglobulin M (IgM) to other types of immunoglobulins (e.g., IgG, IgA, IgE) that are essential for a comprehensive immune defense.
Conducted at DNA Labs UAE, this genetic test is a critical tool for the early detection and management of the condition, allowing for tailored treatment plans that can significantly improve the quality of life for affected individuals. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the CD40 gene that are known to cause the syndrome.
The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed in detecting the genetic abnormalities associated with this immunodeficiency. Early diagnosis through this test can be pivotal in initiating appropriate interventions, including immunoglobulin replacement therapy and other supportive measures, to mitigate the impact of the disease.
The IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the IRF8 gene, which are linked to a rare immunodeficiency disorder. This condition, known as Immunodeficiency 32A, makes affected individuals highly susceptible to mycobacterial infections, including both typical and atypical mycobacteriosis, due to a compromised immune response. The test is crucial for individuals who have a family history of the disorder or present with symptoms indicative of a compromised immune system, especially an unusual susceptibility to mycobacterial infections.
The test is performed using a sample of the patient's blood or saliva, from which DNA is extracted and analyzed for specific mutations in the IRF8 gene that are known to cause the disorder. This genetic test is autosomal dominant, meaning that only one copy of the altered gene in each cell is sufficient to cause the disorder, making it vital for at-risk individuals or those with a family history of the condition to undergo testing.
At DNA Labs UAE, the cost for the IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant Genetic Test is set at 4400 AED. The price reflects the comprehensive nature of the test, encompassing the advanced genetic analysis required to accurately identify the presence of the IRF8 gene mutations. This test not only aids in the diagnosis of the condition but also assists in the development of a personalized treatment plan to manage the symptoms and improve the quality of life for those affected.
